Editorial Board

Sylvia Haas

Sylvia Haas

MD

  • Professor of Medicine
  • Technical University of Munich
  • Munich, Germany

 

Bio

Dr. Haas is a Professor of Medicine and the former Director of the Haemostasis and Thrombosis Research Group at the Institute for Experimental Oncology and Therapy Research, Technical University of Munich in Germany. Professor Haas’s extensive research focused on the development of innovative anticoagulant therapies, laboratory monitoring of anticoagulants, biomarkers, and tumor-associated thrombosis. She is actively involved in several clinical trials centered around the prevention and treatment of arterial and Venous Thromboembolism.

Professor Haas established the Haemostasis and Thrombosis Research Group at the Institute for Experimental Surgery, now the Institute for Experimental Oncology and Therapy Research, at the Technical University of Munich. She is also a member of several editorial boards for peer-reviewed journals, including International Angiology and Clinical and Applied Thrombosis/Hemostasis.

What is the future of
anticoagulation
in the EU?

Welcome to the
coagulation center

Discover clinical perspectives, educational resources and practice tools on balancing the benefit and risk of anticoagulation considering individual patient differences and needs

About the Coagulation Center

The Coagulation Center is an educational resource for healthcare professionals. Guided by a global editorial board of experts, the Coagulation Center offers a range of clinical perspectives on balancing the benefit and risk of anticoagulation in a rapidly changing landscape. Within the Coagulation Center you will find roundtable discussions on anticoagulation management, materials for patient management including patient case studies, tools to help evaluate bleeding risk and stroke risk, and downloadable resources for your practice.